Previously, we showed that eEF2 was overexpressed in the majority of gastric and colorectal cancers and promoted progression of G2/M of the cell cycle in association with activation of Akt and a G2/M regulator, cdc2 proteins, resulting in the enhancement of in vitro and in vivo cancer cell growth (14). Here, EEF2 is linked to colorectal cancer.